The role of Her-2 in penile squamous cell carcinoma progression and cisplatin chemoresistance and potential for antibody-drug conjugate-based therapy

Tan, Xingliang; Wang, Yanjun; Wu, Zhiming; Zhou, Qianghua; Tang, Yi; Liu, Zhicheng; Yuan, Gangjun; Luo, Sihao; Zou, Yuantao; Guo, Shengjie; Han, Na; Yao, Kai

doi:10.1016/j.ejca.2023.113360

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article4

Other1

Relationship

Self Cite0

Independent5

Authors

Journals

Cited by 8 publications

References 54 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Treatments Relevant to Individual Cancer Types

2024

A Beginner's Guide to Targeted Cancer Treatments and Cancer Immunotherapy

View full text Add to dashboard Cite

Treatments Relevant to Individual Cancer Types

2024

A Beginner's Guide to Targeted Cancer Treatments and Cancer Immunotherapy

View full text Add to dashboard Cite

PTBP1 Regulates DNMT3B Alternative Splicing by Interacting With RALY to Enhance the Radioresistance of Prostate Cancer

He,

Zhou,

Zhang

et al. 2024

Advanced Science

View full text Add to dashboard Cite

Radiotherapy is a curative arsenal for prostate cancer (PCa), but radioresistance seriously compromises its effectiveness. Dysregulated RNA splicing factors are extensively involved in tumor progression. Nonetheless, the role of splicing factors in radioresistance remains largely unexplored in PCa. Here, 23 splicing factors that are differentially expressed between PCa and adjacent normal tissues across multiple public PCa databases are identified. Among those genes, polypyrimidine tract binding protein 1 (PTBP1) is significantly upregulated in PCa and is positively associated with advanced clinicopathological features and poor prognosis. Gain‐ and loss‐of‐function experiments demonstrate that PTBP1 markedly reinforces genomic DNA stability to desensitize PCa cells to irradiation in vitro and in vivo. Mechanistically, PTBP1 interacts with the heterogeneous nuclear ribonucleoproteins (hnRNP) associated with lethal yellow protein homolog (RALY) and regulates exon 5 splicing of DNA methyltransferase 3b (DNMT3B) from DNMT3B‐S to DNMT3B‐L. Furthermore, upregulation of DNMT3B‐L induces promoter methylation of dual‐specificity phosphatase‐2 (DUSP2) and subsequently inhibits DUSP2 expression, thereby increasing radioresistance in PCa. The findings highlight the role of splicing factors in inducing aberrant splicing events in response to radiotherapy and the potential role of PTBP1 and DNMT3B‐L in reversing radioresistance in PCa.

show abstract